Pim-1 kinase expression during murine mammary development

Biochemical and Biophysical Research Communications

Volumn 345, Issue 3, 2006, Pages 989-997

  Gapter, Leslie A ^a,b   Magnuson, Nancy S ^b   Ng, Ka yun ^a   Hosick, Howard L ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Breast; Growth and development; Kinase; Mammary cell line; P21CIP Waf1; Pim 1; Progesterone

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PHOSPHOTRANSFERASE; PROGESTERONE; PROTEIN; PROTEIN KINASE PIM 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST CELL; BREAST DEVELOPMENT; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME REGULATION; HISTOPATHOLOGY; HORMONE ACTION; IN VITRO STUDY; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; BREAST; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; PROTO-ONCOGENE PROTEINS C-PIM-1;

MURINAE;

EID: 33646853290     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.110     Document Type: Article

References (57)

1. Topper Y.J., and Freeman C.S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 60 (1980) 1049-1106
2. Groner B., and Gouilleux F. Prolactin-mediated gene activation in mammary epithelial cells. Curr. Opin. Genet. Dev. 5 (1995) 587-594
3. Wang Z., Bhattacharya N., Weaver M., Petersen K., Meyer M., Gapter L., and Magnuson N.S. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci. 2 (2001) 167-179
4. Wang Z., Bhattacharya N., Meyer M.K., Seimiya H., Tsuruo T., Tonani J.A., and Magnuson N.S. Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch. Biochem. Biophys. 390 (2001) 9-18
5. Schmidt T., Karsunky H., Rodel B., Zevnik B., Elsasser H.P., and Moroy T. Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J. 17 (1998) 5349-5359
6. Stewart B.E., and Rice R.H. Differentiation-associated expression of the proto-oncogene pim-1 in cultured human keratinocytes. J. Invest. Dermatol. 105 (1995) 699-703
7. Dautry F., Weil D., Yu J., and Dautry-Varsat A. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J. Biol. Chem. 263 (1988) 17615-17620
8. Lilly M., Le T., Holland P., and Hendrickson S.L. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene 7 (1992) 727-732
9. Miura O., Miura Y., Nakamura N., Quelle F.W., Witthuhn B.A., Ihle J.N., and Aoki N. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84 (1994) 4135-4141
10. Rimon E., Sasson R., Dantes A., Land-Bracha A., and Amsterdam A. Gonadotropin-induced gene regulation in human granulosa cells obtained from IVF patients: modulation of genes coding for growth factors and their receptors and genes involved in cancer and other diseases. Int. J. Oncol. 24 (2004) 1325-1338
11. Buckley A.R., Buckley D.J., Leff M.A., Hoover D.S., and Magnuson N.S. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology 136 (1995) 5252-5259
12. Krumenacker J.S., Narang V.S., J Buckley D., and Buckley A.R. Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase. J. Neuroimmunol. 113 (2001) 249-259
13. Zhu N., M Ramirez L., Lee R.L., Magnuson N.S., Bishop G.A., and Gold M.R. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway. J. Immunol. 168 (2002) 744-754
14. Stout B.A., Bates M.E., Liu L.Y., Farrington N.N., and Bertics P.J. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol. 173 (2004) 6409-6417
15. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., and Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16 (1997) 6926-6935
16. Brantley D.M., Chen C.L., Muraoka R.S., Bushdid P.B., Bradberry J.L., Kittrell F., Medina D., Matrisian L.M., Kerr L.D., and Yull F.E. Nuclear factor-kappa b (NF-κB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell 12 (2001) 1445-1455
17. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., and Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11 (1997) 179-186
18. L Aho T., Sandholm J., Peltola K.J., Mankonen H.P., Lilly M., and Koskinen P.J. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett. 571 (2004) 43-49
19. Bhattacharya N., Wang Z., Davitt C., McKenzie I.F., Xing P.X., and Magnuson N.S. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 111 (2002) 80-95
20. Mochizuki T., Kitanaka C., Noguchi K., Muramatsu T., Asai A., and Kuchino Y. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274 (1999) 18659-18666
21. 2/M specific phosphatase Cdc25C. Int. J. Biochem. Cell Biol. 38 (2006) 430-443
22. Bachmann M., Hennemann H., Xing P.X., Hoffmann I., and Moroy T. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J. Biol. Chem. 279 (2004) 48319-48328
23. Wang Z., Bhattacharya N., Mixter P.F., Wei W., Sedivy J., and Magnuson N.S. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim. Biophys. Acta, Mol. Cell Res. 1593 (2002) 45-55
24. Zhou B.P., Liao Y., Xia W., Spohn B., Lee M., and Hung M. Cytoplasmic localization of p21 Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3 (2001) 245-252
25. Liang H., Hittelman W., and Nagarajan L. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. Arch. Biochem. Biophys. 330 (1996) 259-265
26. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
27. Hoover D., Friedmann M., Reeves R., and Magnuson N.S. Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J. Biol. Chem. 266 (1991) 14018-14023
28. Nagarajan L., Louie E., Tsujimoto Y., ar-Rushdi A., Huebner K., and Croce C.M. Localization of the human pim oncogene (PIM) to a region of chromosome 6 involved in translocations in acute leukemias. Proc. Natl. Acad. Sci. USA 83 (1986) 2556-2560
29. Breuer M., Slebos R., Verbeek S., van Lohuizen M., Wientjens E., and Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 340 (1989) 61-63
30. Hoover D.S., Wingett D.G., Zhang J., Reeves R., and Magnuson N.S. Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor elF-4E. Cell Growth Differ. 8 (1997) 1371-1380
31. Johannes G., Carter M.S., Eisen M.B., Brown P.O., and Sarnow P. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl. Acad. Sci. USA 96 (1999) 13118-13123
32. Gordon L.A., Mulligan K.T., Maxwell-Jones H., Adams M., Walker R.A., and Jones J.L. Breast cell invasive potential relates to the myoepithelial phenotype. Int. J. Cancer 106 (2003) 8-16
33. Saris C.J., Domen J., and Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J. 10 (1991) 655-664
34. deCatanzaro D., Muir C., Beaton E.A., and Jetha M. Non-invasive repeated measurement of urinary progesterone, 17β-estradiol, and testosterone in developing, cycling, pregnant, and postpartum female mice. Steroids 69 (2004) 687-696
35. Hinojosa L., Chavira R., Dominguez R., and Rosas P. Effects of thymulin on spontaneous puberty and gonadotrophin-induced ovulation in prepubertal normal and hypothymic mice. J. Endocrinol. 163 (1999) 255-260
36. Xia W., Chen J.S., Zhou X., Sun P.R., Lee D.F., Liao Y., Zhou B.P., and Hung M.C. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin. Cancer Res. 10 (2004) 3815-3824
37. Imagawa W., Tomooka Y., Hamamoto S., and Nandi S. Stimulation of mammary epithelial growth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116 (1985) 1514-1524
38. Atwood C.S., Hovey R.C., Glover J.P., Chepko G., Ginsburg E., Robinson Jr. W.G., and Vonderhaar B.K. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J. Endocrinol. 167 (2000) 39-52
39. Katakami N., Kaneto H., Hao H., Umayahara Y., Fujitani Y., Sakamoto K., Gorogawa S., Yasuda T., Kawamori D., Kajimoto Y., Matsuhisa M., Yutani C., Hori M., and Yamasaki Y. Role of pim-1 in smooth muscle cell proliferation. J. Biol. Chem. 279 (2004) 54742-54749
40. Qian K.C., Wang L., Hickey E.R., Studts J., Barringer K., Peng C., Kronkaitis A., Li J., White A., Mische S., and Farmer B. Structural basis of constitutive activity and a unique nucleotide binding mode of human pim-1 kinase. J. Biol. Chem. 280 (2005) 6130-6137
41. Rudland P.S. Generation of lobuloalveolar development from isolated rat mammary ducts and end buds. J. Histochem. Cytochem. 39 (1991) 1257-1266
42. P.S. Rudland, R. Barraclough, D.G. Fernig, J.A. Smith, Mammary stem cells in normal development and cancer, Stem Cells, Academic Press, London, 1997.
43. Ismail P.M., Li J., DeMayo F.J., O'Malley B.W., and Lydon J.P. A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. Mol. Endocrinol. 16 (2002) 2475-2489
44. Shi H.Y., Lydon J.P., and Zhang M. Hormonal defect in maspin heterozygous mice reveals a role of progesterone in pubertal ductal development. Mol. Endocrinol. 18 (2004) 2196-2207
45. Neville M.C., Morton J., and Umemura S. Lactogenesis. The transition from pregnancy to lactation. Pediatr. Clin. North Am. 48 (2001) 35-52
46. Ishibashi Y., Maita H., Yano M., Koike N., Tamai K., Ariga H., and Iguchi-Ariga S.M. Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus. FEBS Lett. 506 (2001) 33-38
47. Ionov Y., Le X., Tunquist B.J., Sweetenham J., Sachs T., Ryder J., Johnson T., Lilly M.B., and Kraft A.S. Pim- 1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anti-Cancer Res. 23 (2003) 167-178
48. Zippo A., De Robertis A., Bardelli M., Galvagni F., and Oliviero S. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103 (2004) 4536-4544
49. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., and Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18 (1999) 1223-1234
50. Nosaka T., Kawashima T., Misawa K., Ikuta K., Mui A.L., and Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18 (1999) 4754-4765
51. Afshari C.A., Nichols M.A., Xiong Y., and Mudryj M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ. 7 (1996) 979-988
52. Suzuki A., Tsutomi Y., Akahane K., Araki T., and Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17 (1998) 931-939
53. Owen G.I., Richer J.K., Tung L., Takimoto G., and Horwitz K.B. Progesterone regulates transcription of the p21WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273 (1998) 10696-10701
54. Meeker T.C., Nagarajan L., ar-Rushdi A., and Croce C.M. Cloning and characterization of the human PIM-1 gene: a putative oncogene related to the protein kinases. J. Cell. Biochem. 35 (1987) 105-112
55. Meeker T.C., Loeb J., Ayres M., and Sellers W. The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter. Mol. Cell. Biol. 10 (1990) 1680-1688
56. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A., Sclafani R.A., Lange C.A., and Horwitz K.B. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11 (1997) 1593-1607
57. Lin V.C., Ng E.H., Aw S.E., Tan M.G., Ng E.H., and Bay B.H. Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA. Mol. Endocrinol. 14 (2000) 348-358